C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2001
11/22/2001	WO2001035995A3 Tr3-specific binding agents and methods for their use
11/22/2001	WO2001034805A3 Human vanilloid receptor gene
11/22/2001	WO2001032845A3 Methods for the preparation of (lipo)peptide synthetases and (lipo)peptides produced therewith
11/22/2001	WO2001027269A3 Vip54 protein and related materials
11/22/2001	WO2001027268A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
11/22/2001	WO2001027146A3 Chemokine receptor
11/22/2001	WO2001023597A9 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus
11/22/2001	WO2001014564A3 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby
11/22/2001	WO2000055633A9 Methods of screening for colorectal cancer modulators
11/22/2001	US20010044523 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
11/22/2001	US20010044522 Polypeptides, antibodies against them and nucleic acids encoding them; detecting activated CD4+ T-cells to diagnose a disease or condition of the immune system; screening for immunosuppressants
11/22/2001	US20010044418 Treatment of allergies
11/22/2001	US20010044151 Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
11/22/2001	US20010044148 EBV-infected stomach cancer cell line
11/22/2001	US20010044146 Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
11/22/2001	US20010044144 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
11/22/2001	US20010044135 Chimeric molecules and novel assay system
11/22/2001	US20010044133 Phage-dependent super-production of biologically active protein and peptides
11/22/2001	US20010044118 Immunoassay for LSD and 2-oxo-3-hydroxy-LSD
11/22/2001	CA2409703A1 Novel differentiation inducing process of embryonic stem cell to ectodermal cell and its use
11/22/2001	CA2409414A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001	CA2409361A1 Humanised antibodies to the epidermal growth factor receptor
11/22/2001	CA2409108A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/22/2001	CA2409077A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/22/2001	CA2409031A1 Insecticidal secreted proteins of brevibacillus laterosporus
11/22/2001	CA2408745A1 Anti-angiogenic polypeptides
11/22/2001	CA2408691A1 Compositions and methods for achieving immune suppression
11/22/2001	CA2408513A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001	CA2408374A1 Mutation in the .beta.2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy
11/22/2001	CA2408360A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	CA2408134A1 G-protein coupled receptors
11/22/2001	CA2407707A1 In vitro fucosylation recombinant glycopeptides
11/22/2001	CA2398979A1 Novel bee venom polypeptides and methods of use thereof
11/21/2001	EP1156334A2 Method for screening a substance having promoting activity on hair growth
11/21/2001	EP1156123A1 Method for detecting a variation of GH1 as indicator of growth hormone dysfunction
11/21/2001	EP1156119A2 Anti-cancer gene therapy by modulation of immune or inflammatory response
11/21/2001	EP1156110A2 G-protein coupled receptor (HFGAN72Y)
11/21/2001	EP1156064A2 Cat-mouse chimeric antibody directed to feline diseases and corresponding heterohydridoma
11/21/2001	EP1156061A1 Reagent for the diagnosis of rheumatoid arthritis
11/21/2001	EP1155700A2 Lymphocyte chemoattractant factor and uses thereof
11/21/2001	EP1155131A2 Compositions and methods for non-targeted activation of endogenous genes
11/21/2001	EP1155124A2 In vitro translation system
11/21/2001	EP1155035A2 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof
11/21/2001	EP1155030A1 Novel component of von hippel-lindau tumor suppressor complex and scf ubiquitin ligase
11/21/2001	EP1155028A1 Pigment protein from coral tissue
11/21/2001	EP1154797A2 Multi-mutant diphtheria toxin vaccines
11/21/2001	EP1154769A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen
11/21/2001	EP1154703A1 Method for preparing albumin hydrolysates
11/21/2001	EP1154702A1 Method for preparing an albumin isolate from a substance containing albumin
11/21/2001	EP1154692A1 A method of controlling fungal pathogens, and agents useful for same
11/21/2001	EP0854727B1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
11/21/2001	EP0842191B1 Cyclosporin derivatives with anti-hiv activity
11/21/2001	EP0773962B1 Antibodies which activate an erythropoietin receptor
11/21/2001	EP0765168B1 Combination of a procoagulant and a cytokine or an inducer of cytokine production for the treatment of tumors
11/21/2001	EP0742902B1 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
11/21/2001	EP0711305B1 Protegrins
11/21/2001	EP0536186B1 Bone and cartilage inductive proteins
11/21/2001	CN1323348A Delivery system for porcine somatotropin
11/21/2001	CN1323316A 丙型肝炎三肽抑制剂 Tripeptide inhibitor of hepatitis C
11/21/2001	CN1323221A Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide
11/21/2001	CN1322759A Composition for stimulating megacaryocyte growth and differentiation and process thereof
11/21/2001	CN1075113C Realignment protein of human digestive enzyme and process for their preparation
11/21/2001	CN1075112C Producing process of HEV Protein and method of testing HEV infection
11/21/2001	CN1075078C Producing process of stem cell factor
11/20/2001	US6320037 IBD-associated microbial nucleic acid molecules
11/20/2001	US6320036 GbpA
11/20/2001	US6319716 Generating expression vectors; link heterologous sequences, insert into cells, allow homologous recombination, recover expression vectors
11/20/2001	US6319713 Methods and compositions for polypeptide engineering
11/20/2001	US6319704 Nucleotide sequences coding an enzymatic polypeptide; for use in the diagnosis and treatment of nervous system disorders
11/20/2001	US6319700 Human choline acetyltransferase
11/20/2001	US6319693 Cloning of chicken anemia virus DNA
11/20/2001	US6319690 Preparation and use of gene banks of human antibodies (“human-antibody libraries”)
11/20/2001	US6319689 Nucleotide sequence which code aspartic protease; for treatment of alzheimer's disease, cancer; for hormone processing
11/20/2001	US6319688 Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1)
11/20/2001	US6319687 Pigment epithelium-derived factor: characterization, genomic organization and sequence of PEDF gene
11/20/2001	US6319686 Nucleotide sequences coding binding protein; for use as diagnostic, drug design and therapeutic tools
11/20/2001	US6319685 Polypeptide for generation of amidated agricultral and medical products
11/20/2001	US6319677 Monitoring seed development; evaluate migration of globulins in seed extracts, migration of globulins indicates seed development activity
11/20/2001	US6319669 Nucleotide sequences coding luminescent polypeptides; for use as genetic tools in monitoring intracelular positions of preferential polypeptides and preferential gene expression
11/20/2001	US6319667 Diagnostics and therapy of diseases associated with HHV-8 infections
11/20/2001	US6319503 Fusion protein comprising ubiquitin fused to single epitope-containing segment comprising two or more identical epitopes, wherein segment is not cleaved from protein by exposure to ubiquitin-specific proteases; immunogens
11/20/2001	US6319502 Immunogenic polypeptide; treating malaria
11/20/2001	US6319500 Detection and treatment of infections with immunoconjugates
11/20/2001	US6319499 Administering amount of antibody or fragment thereof effective to activate endogenous activity of erythropoietin receptor in mammal, wherein antibody or fragment thereof interacts with peptide consisting of specified amino acid sequence
11/20/2001	CA2096418C Expression of pace in host cells and methods of use thereof
11/20/2001	CA2084521C Hepatitis c virus antigen polypeptide, production method therefor, and antibody detection method
11/20/2001	CA2077691C Oxidation resistant thrombomodulin analogs
11/20/2001	CA2065022C Rubella peptides
11/20/2001	CA2053864C Modified forms of reproductive hormones
11/19/2001	CA2324167A1 A membrane-bound netrin
11/18/2001	CA2722134A1 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/15/2001	WO2001086293A2 A method for designing and screening random libraries of compounds
11/15/2001	WO2001085993A2 Method for detecting growth hormone variations in humans, the variations and their uses
11/15/2001	WO2001085984A1 Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals
11/15/2001	WO2001085980A2 Enzymatic assays for screening anti-cancer agents
11/15/2001	WO2001085977A2 Chemoenzymatic synthesis of neotame
11/15/2001	WO2001085955A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001	WO2001085952A2 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof
11/15/2001	WO2001085946A2 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
11/15/2001	WO2001085945A1 Method of inhibiting the formation of by-product in the production of genetically modified polypeptide

1 ... 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 ... 1125